| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 6.81B | 6.58B | 6.49B | 5.94B | 4.97B |
| Gross Profit | 900.00M | 1.05B | 1.04B | 1.01B | 820.10M |
| EBITDA | 35.00M | 198.00M | 295.00M | 300.29M | 214.32M |
| Net Income | -7.00M | 91.00M | 171.00M | 179.35M | 124.08M |
Balance Sheet | |||||
| Total Assets | 2.20B | 2.60B | 2.12B | 2.04B | 1.75B |
| Cash, Cash Equivalents and Short-Term Investments | 660.00M | 1.05B | 709.00M | 765.90M | 607.60M |
| Total Debt | 454.00M | 435.00M | 427.00M | 424.99M | 433.59M |
| Total Liabilities | 2.16B | 2.50B | 2.03B | 1.96B | 1.75B |
| Stockholders Equity | 46.00M | 97.00M | 94.00M | 81.28M | -1.77M |
Cash Flow | |||||
| Free Cash Flow | -309.00M | 482.00M | 158.37M | 317.36M | 227.25M |
| Operating Cash Flow | -278.00M | 520.00M | 198.49M | 347.69M | 260.15M |
| Investing Cash Flow | -31.00M | -38.00M | -21.73M | -32.12M | -31.01M |
| Financing Cash Flow | -90.00M | -173.00M | -155.01M | -141.15M | -208.07M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $3.18B | 13.73 | 13.94% | 2.89% | 3.65% | 5.71% | |
71 Outperform | $719.30M | 16.87 | 23.66% | 0.88% | 9.64% | 9.93% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | $2.29B | 20.45 | 10.26% | 8.65% | -7.27% | -43.88% | |
51 Neutral | $1.23B | 11.44 | -0.65% | 4.96% | -2.44% | -156.01% | |
48 Neutral | $1.78B | 18.31 | 111.30% | 1.81% | 0.99% | -47.02% | |
43 Neutral | $887.00M | -210.19 | -7.69% | 6.37% | 3.19% | -86.21% |
On February 10, 2026, Insperity announced a Realignment Plan that will eliminate about 4% of its non-sales roles as part of an internal reorganization aimed at boosting efficiency and sharpening focus on key business areas, with an estimated $9 million in one-time severance and related charges largely recognized in the first quarter of 2026 and excluded from non-GAAP metrics. The company also reported a 2025 net loss of $7 million despite 4% revenue growth to $6.8 billion and modest WSEE gains, as elevated benefits costs pressured margins, prompting management to emphasize margin recovery, cost efficiencies and disciplined hiring, while returning $109 million to shareholders in 2025 and issuing 2026 guidance that points to a planned rebound in adjusted EBITDA and earnings.
The most recent analyst rating on (NSP) stock is a Hold with a $42.00 price target. To see the full list of analyst forecasts on Insperity stock, see the NSP Stock Forecast page.